Attempts to test the effectiveness of Acinetobacter glutaminasificans glutaminase-asparaginase against acute lymphoblast leukemia in patients were discontinued due to strong side effects, presumably due to high glutaminase activity [124,125]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.